fumonisin-b1 and Leukemia-P388
fumonisin-b1 has been researched along with Leukemia-P388* in 1 studies
Other Studies
1 other study(ies) available for fumonisin-b1 and Leukemia-P388
Article | Year |
---|---|
Inflammatory activation of arachidonic acid signaling in murine P388D1 macrophages via sphingomyelin synthesis.
Ceramide has emerged as an important lipid messenger for many cellular processes triggered via surface receptors. In the present study, inflammatory activation of P388D1 macrophages with bacterial lipopolysaccharide (LPS) and platelet-activating factor (PAF) stimulated a transient accumulation of ceramide. Moreover, cell-permeable ceramide mimicked LPS/PAF in triggering arachidonate mobilization in these cells. LPS/PAF-induced ceramide synthesis did not result from sphingomyelinase activation but from increased de novo synthesis. Participation of this pathway in arachidonate signaling was detected since fumonisin B1, an inhibitor of de novo ceramide synthesis, was able to inhibit the LPS/PAF-induced response. These studies have uncovered a new role for sphingolipid metabolism in cellular signaling and constitute evidence that products of the sphingomyelin biosynthetic pathway may serve a specific role in signal transduction by influencing the activity of the novel Group V secretory phospholipase A2. Topics: Animals; Arachidonic Acid; Carboxylic Acids; Diglycerides; Fumonisins; Leukemia P388; Lipopolysaccharides; Macrophages; Mice; Platelet Activating Factor; Sphingomyelins; Tumor Cells, Cultured | 1997 |